Doctors seek safer stroke drug dose to stop brain damage
NCT ID NCT07047326
Summary
This study aims to find the safest and most effective dose of a clot-dissolving drug called urokinase for people having a stroke. Researchers will test different doses in 24 patients who arrive at the hospital within 6 hours of stroke symptoms starting. The main goal is to create a standard, weight-based dosing plan to improve safety and treatment results.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Xuanwu Hospital, Capital Medical University
RECRUITINGBeijing, Beijing Municipality, 100053, China
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.